The PE Ratio as of November 2024 (TTM) for Portage Biotech Inc. (PRTG) is 0.19

According to Portage Biotech Inc.’s latest financial reports and current stock price. The company's current PE Ratio is 0.19. This represents a change of -101.73% compared to the average of -10.97 of the last 4 quarters.

Portage Biotech Inc. (PRTG) Historical PE Ratio (quarterly & annually)

How has PRTG PE Ratio performed in the past?

The mean historical PE Ratio of Portage Biotech Inc. over the last ten years is -128.97. The current 0.19 PE Ratio has changed -114.73% with respect to the historical average. Over the past ten years (40 quarters), PRTG's PE Ratio was at its highest in in the September 2016 quarter at 4.53. The PE Ratio was at its lowest in in the September 2017 quarter at -2391.61.

Portage Biotech Inc. (PRTG) PE Ratio by Quarter and Year

Discovering the peaks and valleys of Portage Biotech Inc. PE Ratio, unveiling quarterly and yearly fluctuations to gain insights into the company’s financial performance and market dynamics, offering valuable data for investors and analysts alike.

Portage Biotech Inc. (PRTG) Average PE Ratio

How has PRTG PE Ratio performed in the past?

The current PE Ratio of Portage Biotech Inc. (PRTG) is greater than its 3-year, greater than its 5-year, and greater than its 10-year historical averages

Portage Biotech Inc. (PRTG) PE Ratio vs. Peers

How is PRTG’s PE Ratio compared to its peers?

Portage Biotech Inc.’s PE Ratio is greater than Amylyx Pharmaceuticals, Inc. (-1.38), greater than Karuna Therapeutics, Inc. (-37.08), greater than Blueprint Medicines Corporation (-46.60), greater than Arvinas, Inc. (-6.04), greater than Aerovate Therapeutics, Inc. (-0.91), greater than Eliem Therapeutics, Inc. (-2.42), greater than Anebulo Pharmaceuticals, Inc. (-4.78), greater than Cue Biopharma, Inc. (-1.17), greater than Decibel Therapeutics, Inc. (-1.95), greater than Keros Therapeutics, Inc. (-11.12), greater than Janux Therapeutics, Inc. (-45.40), greater than Fennec Pharmaceuticals Inc. (-120.74), greater than Edgewise Therapeutics, Inc. (-24.30), less than Harmony Biosciences Holdings, Inc. (15.80), greater than Lineage Cell Therapeutics, Inc. (-4.73), greater than MAIA Biotechnology, Inc. (-1.92), greater than Armata Pharmaceuticals, Inc. (-1.97), greater than Frequency Therapeutics, Inc. (-0.49), greater than Day One Biopharmaceuticals, Inc. (-15.73), greater than Acumen Pharmaceuticals, Inc. (-1.74), greater than X4 Pharmaceuticals, Inc. (-4.05), greater than Inozyme Pharma, Inc. (-1.84), greater than VectivBio Holding AG (-7.94),

Build a custom stock screener for Portage Biotech Inc. (PRTG) and other stocks

One of the best ways to find valuable stocks to invest in is to build a custom made screener in your Excel or Google Sheets spreadsheet. This allows you to compare thousands of companies like Portage Biotech Inc. using the financials and key metrics that matter to you in a single view.

The easiest way to set this up is to use the Wisesheets add-on and set your spreadsheet like this:

Covering all these metrics from financial, data, dividend data, key metrics and more you can get all the data you want for over 50+ exchanges worldwide.

Get your free trial here.

Portage Biotech Inc. (PRTG) and other stocks custom spreadsheet templates

The easiest way to analyze a company like Portage Biotech Inc. or any others is to create a spreadsheet model that automatically retrieves all of the stock data you need.

Using Wisesheets you can set up a spreadsheet model like this with simple spreadsheet formulas. If you change the ticker you can get all of the data automatically updated for you.

Whether you need live data, historical price data, financials, dividend data, key metrics, analyst estimates, or anything else...Wisesheets has you covered.